Overview

Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting

Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Prospective, observational study evaluating the effect of olanzapine for the treatment of refractory chronic nausea and vomiting.
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Olanzapine